{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:03:11Z","timestamp":1783645391344,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.1007\/bf00665783","type":"journal-article","created":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T07:26:34Z","timestamp":1101799594000},"page":"97-117","source":"Crossref","is-referenced-by-count":114,"title":["MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo"],"prefix":"10.1007","volume":"34","author":[{"given":"Yiliang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorraya","family":"El-Ashry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Yi Fan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis G.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1073\/pnas.90.7.2900","volume":"90","author":"MH Kraus","year":"1993","unstructured":"Kraus MH, Fedi P, Starks V, Muraro R, Aaronson SA: Demonstration of ligand-dependent signaling by theerb-B3 tyrosine kinase and its constitutive activation in human breast tumor cells. Proc Natl Acad Sci USA 90: 2900?2904, 1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1073\/pnas.90.5.1746","volume":"90","author":"GD Plowman","year":"1993","unstructured":"Plowman GD, Culouscou J-M, Whitney GS, Green JM, Carolton GW, Foy L, Neubauer MG, Shoyab M: Ligand-specific activation of HER4\/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90: 1746?1750, 1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/319226a0","volume":"319","author":"CL Bargmann","year":"1986","unstructured":"Bargmann CL, Hung M-C, Weinberg RA: The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319: 226?230, 1986","journal-title":"Nature"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.2999974","volume":"230","author":"L Coussens","year":"1985","unstructured":"Coussens L, Yang-Feng T, Liao Y-C, Chen L, Gray A, McGrath J, Seeburg PH, Lieberman TA, Schlessinger J, Francke U, Levinson A, Ullrich A: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132?1139, 1985","journal-title":"Science"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1073\/pnas.87.13.4905","volume":"87","author":"GD Plowman","year":"1990","unstructured":"Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ, Shoyab M: Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87:4905?4909, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR6","first-page":"992","volume":"2","author":"F Lonardo","year":"1990","unstructured":"Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA, Di Fiore PP: The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol 2: 992?1003, 1990","journal-title":"New Biol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0092-8674(87)90592-7","volume":"51","author":"P DiFiore","year":"1987","unstructured":"DiFiore P, Pierce J, Fleming T, Hazan R, Ullrich A, King CR, Schlessinger J, Aaronson S: Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51: 1063?1070, 1987","journal-title":"Cell"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1073\/pnas.84.20.7159","volume":"84","author":"RM Hudziak","year":"1987","unstructured":"Hudziak RM, Schlessinger J, Ullrich A: Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH3T3 cells. Proc Natl Acad Sci USA 84: 7159?7163, 1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.2885917","volume":"237","author":"PP DiFiore","year":"1987","unstructured":"DiFiore PP, Pierce J, Kraus M, Segatto O, King CR, Aaronson SA: erb-B2 is a potent oncogene when overexpressed in NIH\/3T3 cells. Science 237: 178?182, 1987","journal-title":"Science"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0959-8049(92)90429-6","volume":"28","author":"BA Gusterson","year":"1992","unstructured":"Gusterson BA: Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression. Eur J Cancer 28: 263?267, 1992","journal-title":"Eur J Cancer"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich Aet al.: Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707?712, 1989","journal-title":"Science"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235: 177?182, 1987","journal-title":"Science"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/bjc.1991.78","volume":"63","author":"TJ Perren","year":"1991","unstructured":"Perren TJ: cv-erbB-2 oncogene as a prognostic marker in breast cancer [editorial]. Br J Cancer 63: 328?332, 1991","journal-title":"Br J Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1991.100","volume":"63","author":"WJ Gullick","year":"1991","unstructured":"Gullick WJ, Love SB, Wright C, Barnes DM, Gusterson B, Harris AL, Altman DG: c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 63: 434?438, 1991","journal-title":"Br J Cancer"},{"key":"CR15","first-page":"449","volume":"3","author":"RF Lodato","year":"1990","unstructured":"Lodato RF, Maguire HC Jr, Greene MI, Weiner DB, LiVolsi VA: Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinomain situ and atypical ductal hyperplasia of the breast. Mod Pathol 3: 449?454, 1990","journal-title":"Mod Pathol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0046-8177(92)90257-4","volume":"23","author":"DC Allred","year":"1992","unstructured":"Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL: Overexpression of HER-2\/neu and its relationship with other prognostic factors change during the progression ofin situ to invasive breast cancer. Hum Pathol 23: 974?979, 1992","journal-title":"Hum Pathol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJM198811103191902","volume":"319","author":"MJ Vijver van de","year":"1988","unstructured":"van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R: Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinomain situ and limited prognostic value in stage II breast cancer. N Engl J Med 319: 1239?1245, 1988","journal-title":"N Engl J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/290261a0","volume":"290","author":"C Shih","year":"1981","unstructured":"Shih C, Padhy LC, Murray M, Weinberg RA: Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261?264, 1981","journal-title":"Nature"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(86)90779-8","volume":"45","author":"CJ Bargmann","year":"1986","unstructured":"Bargmann CJ, Hung M-C, Weinberg RA: Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain. Cell 45: 649?657, 1986","journal-title":"Cell"},{"key":"CR20","first-page":"237","volume":"5","author":"NR Lemoine","year":"1990","unstructured":"Lemoine NR, Staddon S, Dickson C, Barnes DM, Gullick WJ: Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene 5: 237?239, 1990","journal-title":"Oncogene"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1073\/pnas.89.22.10578","volume":"89","author":"CT Guy","year":"1992","unstructured":"Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ: Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578?10582, 1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR22","first-page":"1189","volume":"6","author":"JH Pierce","year":"1991","unstructured":"Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, Di Fiore PP, Aaronson SA: Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6: 1189?1194, 1991","journal-title":"Oncogene"},{"key":"CR23","first-page":"407","volume":"1","author":"F Ciardiello","year":"1990","unstructured":"Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H: Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Cell Growth Differ 1: 407?420, 1990","journal-title":"Cell Growth Differ"},{"key":"CR24","first-page":"1797","volume":"8","author":"B D'Souza","year":"1993","unstructured":"D'Souza B, Berdichevsky F, Kyprianou N, Taylor-Papadimitriou J: Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells. Oncogene 8: 1797?1806, 1993","journal-title":"Oncogene"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0959-8049(05)80129-7","volume":"28","author":"EM Berns","year":"1992","unstructured":"Berns EM, Klijn JG, van Staveren IL, Portengen H, Noordegraaf E, Foekens JA: Prevalence of amplification of the oncogenes c-myc, HER2\/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. Eur J Cancer 28: 697?700, 1992","journal-title":"Eur J Cancer"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/bjc.1992.22","volume":"65","author":"C Wright","year":"1992","unstructured":"Wright C, Nicholson S, Angus B, Sainsbury JR, Farndon J, Cairns J, Harris AL, Horne CH: Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br J Cancer 65: 118?121, 1992","journal-title":"Br J Cancer"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0022-4731(89)90071-X","volume":"34","author":"ME Lippman","year":"1989","unstructured":"Lippman ME, Dickson RB: Mechanisms of normal and malignant breast epithelial growth regulation. J Steroid Biochem 34: 107?121, 1989","journal-title":"J Steroid Biochem"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/edrv-8-1-29","volume":"8","author":"R Dickson","year":"1987","unstructured":"Dickson R, Lippman ME: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 8: 29?43, 1987","journal-title":"Endocr Rev"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0022-4731(89)90071-X","volume":"34","author":"ME Lippman","year":"1989","unstructured":"Lippman ME, Dickson RB: Mechanisms of normal and malignant breast epithelial growth regulation. J Steroid Biochem 34: 107?121, 1989","journal-title":"J Steroid Biochem"},{"key":"CR30","unstructured":"Miller DL, El-Ashry D, Cheville AL, Liu Y, McLeskey SW, Kern FG: Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ, submitted: 1994"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/MCB.7.8.2745","volume":"7","author":"C Chen","year":"1987","unstructured":"Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745?2752, 1987","journal-title":"Mol Cell Biol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1021\/bi00393a045","volume":"26","author":"PA Estes","year":"1987","unstructured":"Estes PA, Suba EJ, Lawler-Heavner J, Elashry-Stowers D, Wei LL, Toft DO, Sullivan WP, Horwitz KB, Edwards DP: Immunological analysis of progesterone receptors in human breast cancer. I. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies. Biochemistry 26: 6250?6262, 1987","journal-title":"Biochemistry"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"M Bradford","year":"1976","unstructured":"Bradford M: A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248?254, 1976","journal-title":"Anal Biochem"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1210\/endo-107-4-884","volume":"107","author":"DP Edwards","year":"1980","unstructured":"Edwards DP, McGuire WL: 17-beta estradiol is a biologically active estrogen in human breast cancer cells in tissue culture. Endocrinology 107: 884?891, 1980","journal-title":"Endocrinology"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/j.1460-2075.1987.tb04797.x","volume":"6","author":"MH Kraus","year":"1990","unstructured":"Kraus MH, Popescu NC, Amsbaugh SC, King CR: Over-expression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6: 605?610, 1990","journal-title":"EMBO J"},{"key":"CR36","first-page":"72","volume":"1","author":"JC Sarup","year":"1991","unstructured":"Sarup JC, Johnson RM, King KL, Fendly BM, Lipari MT, Napier MA, Ullrich A, Shepard HM: Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth. Growth Regul 1: 72?82, 1991","journal-title":"Growth Regul"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01961241","volume":"24","author":"CC Benz","year":"1993","unstructured":"Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM, Osborne CK: Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2\/neu. Breast Cancer Res Treat 24: 85?95, 1993","journal-title":"Breast Cancer Res Treat"},{"key":"CR38","first-page":"3947","volume":"50","author":"LD Read","year":"1990","unstructured":"Read LD, Keith D Jr, Slamon DJ, Katzenellenbogen BS: Hormonal modulation of HER-2\/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Cancer Res 50: 3947?3951, 1990","journal-title":"Cancer Res"},{"key":"CR39","first-page":"1001","volume":"5","author":"C Dati","year":"1990","unstructured":"Dati C, Antoniotti S, Taverna D, Perroteau I, De Bortoli M: Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene 5: 1001?1006, 1990","journal-title":"Oncogene"},{"key":"CR40","first-page":"13","volume":"4","author":"CR King","year":"1989","unstructured":"King CR, Borrello I, Porter L, Comoglio P, Schlessinger J: Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2\/neu proto-oncogene product is induced by hyperosmotic shock. Oncogene 4: 13?18, 1989","journal-title":"Oncogene"},{"key":"CR41","first-page":"161","volume":"16","author":"TC Holme","year":"1990","unstructured":"Holme TC: Cancer cell structure: actin changes in tumour cells - possible mechanisms for malignant tumour formation. Eur J Surg Oncol 16: 161?169, 1990","journal-title":"Eur J Surg Oncol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/0277-5379(87)90062-9","volume":"23","author":"WV Welshons","year":"1987","unstructured":"Welshons WV, Jordan VC: Adaption of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. Eur J Cancer Clin Oncol 23: 1935?1939, 1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mc.2940060108","volume":"6","author":"F Ciardiello","year":"1992","unstructured":"Ciardiello F, Gottardis M, Basolo F, Pepe S, Normanno N, Dickson RB, Bianco AR, Salomon DS: Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes onin vitro transformation of human mammary epithelial cells. Mol Carcinog 6: 43?52, 1992","journal-title":"Mol Carcinog"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1073\/pnas.86.10.3649","volume":"86","author":"R Clarke","year":"1989","unstructured":"Clarke R, Br\u00fcnner N, Katzenellenbogen BS, Thompson EW, Norman MJ, Koppi C, Paik S, Lippman ME, Dickson RB: Progression of human breast cancer cells from hormone-dependent to hormone-independent growth bothin vitro andin vivo. Proc Natl Acad Sci USA 86: 3649?3653, 1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR45","first-page":"4355","volume":"47","author":"BS Katzenellenbogen","year":"1987","unstructured":"Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y: Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res 47: 4355?4360, 1987","journal-title":"Cancer Res"},{"key":"CR46","unstructured":"Zhang L, Ding IYF, Kharbanda S, McLeskey SW, Honig S, Chen D, Kern FG: MCF-7 breast carcinoma cells overexpressing recombinant FGF-1 cDNAs with or without an appended signal peptide form vascularized, metastatic tumors in ovariectomized nude mice. Cancer Res, submitted: 1994"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0959-8049(05)80045-0","volume":"28","author":"S Antoniotti","year":"1992","unstructured":"Antoniotti S, Maggiora P, Dati C, De Bortoli M: Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cellsin vitro. Eur J Cancer 28: 318?321, 1992","journal-title":"Eur J Cancer"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(85)91385-6","volume":"1","author":"JRC Sainsbury","year":"1985","unstructured":"Sainsbury JRC, Farndon JR, Sherbet GV, Harris AL: Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet 1: 364?366, 1985","journal-title":"Lancet"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1210\/endo-118-1-138","volume":"118","author":"RB Dickson","year":"1986","unstructured":"Dickson RB, Huff KK, Spencer EM, Lippman ME: Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cells. Endocrinology 118: 138?142, 1986","journal-title":"Endocrinology"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.93.1.1","volume":"93","author":"DW Barnes","year":"1982","unstructured":"Barnes DW: Epidermal growth factor inhibits the growth of A431 epidermoid carcinoma in serum-free cell culture. J Cell Biol 93: 1?4, 1982","journal-title":"J Cell Biol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.86.19.7432","volume":"86","author":"M Kan","year":"1989","unstructured":"Kan M, Huang J, Mansson P-E, Yasumitsu H, Carr B, McKeehan WL: Heparin-binding growth factor type 1 (acidic fibroblast growth factor): A potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci USA 86: 7432?7436, 1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.2218496","volume":"249","author":"L Lupu","year":"1990","unstructured":"Lupu L, Colomer R, Zugmaier G, Sarup J, Shepard M, Slamon D, Lippman ME: Direct interaction of a ligand for the erbB-2 oncogene product with the EGF receptor and p185erbB-2. Science 249: 1552?1555, 1990","journal-title":"Science"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0092-8674(92)90131-U","volume":"69","author":"E Peles","year":"1992","unstructured":"Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y: Isolation of the neu\/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69: 205?216, 1992","journal-title":"Cell"},{"key":"CR54","first-page":"401","volume":"3","author":"SS Bacus","year":"1992","unstructured":"Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M, Lupu R: A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. Cell Growth Differ 3: 401?411, 1992","journal-title":"Cell Growth Differ"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.256.5060.1205","volume":"256","author":"WE Holmes","year":"1992","unstructured":"Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard HM, Kuang W-J, Wood WI, Goeddel DV, Vandlen RL: Identification of heregulin, a specific activator of p185erbB2 Science 256: 1205?1210, 1992","journal-title":"Science"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/366473a0","volume":"366","author":"GD Plowman","year":"1993","unstructured":"Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM: Heregulin induces tyrosine phosphorylation of HER4\/p180 (ErbB4). Nature 366: 473?475, 1993","journal-title":"Nature"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/j.1460-2075.1988.tb02991.x","volume":"7","author":"CR King","year":"1988","unstructured":"King CR, Borrello I, Bellot F, Comoglio P, Schlessinger J: EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J 7: 1647?1651, 1988","journal-title":"EMBO J"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/j.1460-2075.1988.tb02906.x","volume":"7","author":"DF Stern","year":"1988","unstructured":"Stern DF, Kamps MP: EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions. EMBO J 7: 995?1001, 1988","journal-title":"EMBO J"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/j.1460-2075.1993.tb05737.x","volume":"12","author":"E Peles","year":"1993","unstructured":"Peles E, Ben-Levy R, Tzahar E, Liu N, Wen D, Yarden Y: Cell-type specific interaction of Neu differentiation factor (NDF\/heregulin) with Neu\/HER-2 suggests complex ligand-receptor relationships. EMBO J 12: 961?971, 1993","journal-title":"EMBO J"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1073\/pnas.91.5.1711","volume":"91","author":"A Samanta","year":"1994","unstructured":"Samanta A, LeVea CM, Dougall WC, Qian XL, Greene MI: Ligand and p185 (c-neu) density govern receptor interactions and tyrosine kinase activation. Proc Natl Acad Sci USA 91: 1711?1715, 1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR61","first-page":"2168","volume":"53","author":"SW McLeskey","year":"1993","unstructured":"McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG: Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res 53: 2168?2177, 1993","journal-title":"Cancer Res"},{"key":"CR62","first-page":"639","volume":"6","author":"YZ Lin","year":"1991","unstructured":"Lin YZ, Clinton GM: A soluble protein related to the HER-2 proto-oncogene product is released from human breast carcinoma cells. Oncogene 6: 639?643, 1991","journal-title":"Oncogene"},{"key":"CR63","first-page":"2593","volume":"51","author":"BC Langton","year":"1991","unstructured":"Langton BC, Crenshaw MC, Chao LA, Stuart SG, Akita RW, Jackson JE: An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2\/neu) oncogene. Cancer Res 51: 2593?2598, 1991","journal-title":"Cancer Res"},{"key":"CR64","first-page":"591","volume":"1","author":"O Alper","year":"1990","unstructured":"Alper O, Yamaguchi K, Hitomi J, Honda S, Matsushima T, Abe K: The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3. Cell Growth Differ 1: 591?599, 1990","journal-title":"Cell Growth Differ"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1128\/MCB.13.4.2247","volume":"13","author":"GK Scott","year":"1993","unstructured":"Scott GK, Robles R, Park JW, Montgomery PA, Daniel J, Holmes WE, Lee J, Keller GA, Li WL, Fendly BM: A truncated intracellular HER2\/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells. Mol Cell Biol 13: 2247?2257, 1993","journal-title":"Mol Cell Biol"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/MCB.9.2.671","volume":"9","author":"A Basu","year":"1989","unstructured":"Basu A, Raghunath M, Bishayee S, Das M: Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol Cell Biol 9: 671?677, 1989","journal-title":"Mol Cell Biol"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/MCB.11.3.1454","volume":"11","author":"O Kashles","year":"1991","unstructured":"Kashles O, Yarden Y, Fischer R, Ullrich A, Schlessinger J: A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol Cell Biol 11: 1454?1463, 1991","journal-title":"Mol Cell Biol"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1128\/MCB.12.2.883","volume":"12","author":"TW Flickinger","year":"1992","unstructured":"Flickinger TW, Maihle NJ, Kung HJ: An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation. Mol Cell Biol 12: 883?893, 1992","journal-title":"Mol Cell Biol"},{"key":"CR69","first-page":"2272","volume":"53","author":"YF Zhai","year":"1993","unstructured":"Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW: Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 53: 2272?2278, 1993","journal-title":"Cancer Res"},{"key":"CR70","first-page":"1991","volume":"6","author":"DH Yu","year":"1991","unstructured":"Yu DH, Hung MC: Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene 6: 1991?1996, 1991","journal-title":"Oncogene"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/82.20.1633","volume":"82","author":"K Yusa","year":"1990","unstructured":"Yusa K, Sugimoto Y, Yamori T, Yamamoto T, Toyoshima K, Tsuruo T: Low metastatic potential of clone from murine colon adenocarcinoma 26 increased by transfection of activated c-erbB-2 gene. J Natl Cancer Inst 82: 1633?1636, 1990","journal-title":"J Natl Cancer Inst"},{"key":"CR72","first-page":"717","volume":"50","author":"JE Price","year":"1990","unstructured":"Price JE, Polyzos A, Zhang RD, Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50: 717?721, 1990","journal-title":"Cancer Res"},{"key":"CR73","first-page":"2178","volume":"53","author":"J Kurebayashi","year":"1993","unstructured":"Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG: Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res 53: 2178?2187, 1993","journal-title":"Cancer Res"},{"key":"CR74","first-page":"4327","volume":"38","author":"LW Engel","year":"1978","unstructured":"Engel LW, Young NA: Human breast carcinoma cells in continuous culture: a review. Cancer Res 38: 4327?4339, 1978","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00665783.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00665783\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00665783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T03:33:24Z","timestamp":1554435204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00665783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["BF00665783"],"URL":"https:\/\/doi.org\/10.1007\/bf00665783","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}